Keyphrases
HER2 Metastatic Breast Cancer
100%
Cyclin-dependent Kinase 4 (CDK4)
100%
ER +
100%
IL-24
83%
Chemokine Ligands
83%
Palbociclib
50%
CDC1
50%
Natural Killer Cells
33%
Immune Response
33%
Natural Killer
33%
MRNA Expression
33%
Dendritic Cells
33%
Treatment Response
33%
Tumor Microenvironment
33%
Circulating Tumor Cell Count
16%
Cyclin E1
16%
IL-10 Family
16%
Tissue Staining
16%
Cell Killing
16%
Fulvestrant
16%
Patient Stratification
16%
Relative Resistance
16%
HER2 Breast Cancer
16%
Cance
16%
Functional Axis
16%
Intrinsic Molecular Subtypes
16%
Metastatic Breast Cancer
16%
Breast Cancer Patients
16%
Molecular Biomarkers
16%
Successful Completion
16%
Personalized Medicine
16%
Retrospective Analysis
16%
Patient Demographics
16%
Breast
16%
Human Epidermal Growth Factor Receptor 2 (HER2)
16%
Basic Scientist
16%
Multiplex
16%
Mechanistic Insight
16%
Patient Samples
16%
Response Rate
16%
Peripheral Blood
16%
Specific Intent
16%
Novel Biomarkers
16%
Enhanced Response
16%
Immunophenotyping
16%
Immune Regulation
16%
Clinical Trials
16%
Clinical Model
16%
Patient Care
16%
Collaborative Teams
16%
Clinical Samples
16%
Cancer-specific
16%
Non-immune
16%
Proposed Work
16%
T Cells
16%
Growth Inhibition
16%
CD8+ T Cells
16%
Gene Expression Analysis
16%
Treatment Options
16%
Antiproliferative Activity
16%
Molecular Profiling
16%
Flow Cytometry
16%
Medicine and Dentistry
Cytokine
100%
Metastatic Breast Cancer
100%
Lymphotactin
83%
Interleukin 24
83%
Palbociclib
50%
Biological Marker
50%
Treatment Response
33%
Tumor Microenvironment
33%
Dendritic Cell
33%
Natural Killer Cell
33%
Messenger RNA
33%
Patient Population
16%
Clinical Finding
16%
Flow Cytometry
16%
Personalized Medicine
16%
Proliferating Cell Nuclear Antigen
16%
Growth Inhibition
16%
Fulvestrant
16%
Molecular Profiling
16%
Cell Killing
16%
Breast Cancer
16%
Circulating Tumor Cell
16%
Cell Count
16%
Malignant Neoplasm
16%
T Cell
16%
Clinician
16%
Cytotoxic T-Cell
16%
Gene Expression Profiling
16%
Clinical Trial
16%
Immunophenotyping
16%
Interleukin 10
16%
Biochemistry, Genetics and Molecular Biology
Cytokine
100%
Interleukin 24
83%
Lymphotactin
83%
Dendritic Cell
33%
T Cell
33%
Messenger RNA
33%
Natural Killer Cell
33%
Immunophenotyping
16%
Interleukin 10
16%
Growth Inhibition
16%
Gene Expression Profiling
16%
CD8
16%
Cell Count
16%
Cell Killing
16%
Flow Cytometry
16%
Clinical Trial
16%
Cyclin E1
16%
Fulvestrant
16%